28
Apr
On 26 April, the proposal for the pharma package review was issued by the Commission. The revision is the first major review of the pharmaceutical legislation since 2004 and aims to adapt the European pharmaceutical legislation to the needs of the 21st century. The reform aims to ensure more timely and equal access, lower burdens on companies, and lower healthcare costs.
The review encompasses two legislative proposals, a Directive, and a Regulation, which will serve as the EU regulatory framework...